Accelerating Pharma Innovation with AI – Executive Roundtable
Join us on May 27th from 3:00 PM to 5:00 PM for an exclusive Executive Roundtable designed specifically for IT leaders within the Pharmaceutical industry. This private, vendor-free, and peer-only session, part of the AI Networking Summit at the Hyatt Regency Dallas @Reunion Tower, will focus on harnessing AI to accelerate innovation, enhance patient outcomes, and optimize operations across Pharma organizations.
Guided by Chatham House Rules with no recordings permitted, this session provides a unique forum to discuss practical strategies, overcome pressing challenges, and explore transformative opportunities presented by AI.
Apply here to join your peers in this vital dialogue shaping the future of AI in Pharma. A networking reception will follow the roundtable.
Potential Discussion Topics:
- Agentic AI Adoption: Evaluating the opportunities and risks associated with implementing agentic AI systems to autonomously perform tasks and make decisions in pharmaceutical contexts.
- Scalable AI Integration: How are Pharma leaders embedding AI seamlessly into existing R&D, clinical trials, and manufacturing processes?
- Data Governance and Compliance: Navigating the complex landscape of data privacy, ethical use, and regulatory adherence within AI-driven Pharma applications.
- AI-Driven Drug Discovery: Exploring real-world case studies of how AI is accelerating drug discovery and reducing time-to-market.
- AI Talent Gap: Addressing the shortage of skilled AI professionals and identifying successful strategies for building internal AI capabilities within Pharma.
- Operational Excellence: Leveraging AI to optimize costs, manage resources effectively, and streamline supply chain and logistics in Pharma.
- AI and Patient-Centric Outcomes: Enhancing patient care through predictive analytics, personalized medicine, and improved clinical trial efficiencies powered by AI.
- Ethics, Transparency, and Trust: Ensuring responsible AI practices that reinforce trust among patients, providers, and regulatory bodies.
Join your peers in this vital dialogue shaping the future of AI in Pharma. A networking reception will follow the roundtable.
James Beeson is the former Chief Information Security Office at Cigna (retired). He was responsible for all aspects of cyber security and digital information protection for Cigna globally. James also had a robust 20-year career working for General Electric in various security and technology leadership positions.
He has an MBA in Finance from Southern Methodist University – Cox School of Business and a BBA in Business from Amberton University.
Sean is the Associate Vice President of Cloud and Infrastructure Technology at Merck and Co., Inc. He has more than 20+ years of experience in the technology industry spanning infrastructure, cyber security, and cloud. Sean is currently responsible for leading Merck’s overall cloud strategy and implementation of foundational technologies and services to enable cloud adoption. Merck is currently undertaking a comprehensive IT Transformation program, leveraging cloud migrations as a catalyst to drive significant operating model and ways of working changes into the organization. Prior to this role, Sean has also worked at REAN Cloud, a Virginia-based technology startup, as their Executive Director where he was responsible for leading the Enterprise Health & Life Sciences business along with driving company-wide Information Security, Compliance, and Quality initiatives. Sean is recognized within the industry for introducing disruptive, cutting-edge cloud thinking into the highly regulated Life Sciences and computing landscape. Sean has previously served as a member of the AWS customer advisory board and was a core member of the AWS GxP working group.
